Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Rivory

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|July 31, 1998
The detection of photodegradation products of irinotecan (CPT-11, Campto, Camptosar), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometryH M Dodds, J Robert, L P Rivory
Clinical Pharmacokinetics|February 24, 2001
Clinical and preclinical pharmacokinetics of raltitrexedS J Clarke, P J Beale, L P Rivory
Cancer Chemotherapy and Pharmacology|January 1, 1996
Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicinL P Rivory, K M Avent, S M Pond
Journal of Chromatography. B, Biomedical Sciences and Applications|October 10, 1998
Trace analysis of SN-38 in human plasma by high-performance liquid chromatographyL P Rivory, M Findlay, S Clarke, et al.
Journal of the National Cancer Institute|January 16, 1999
More about: irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatinH M Dodds, J F Bishop, L P Rivory
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1992
Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugsL P Rivory, M S Roberts, S M Pond
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1993
Physiological pharmacokinetics of solutes in the isolated perfused rat hindlimb: characterization of the physiology with changing perfusate flow, protein content, and temperature using statistical moment analysisZ Y Wu, L P Rivory, M S Roberts
Biochemical Pharmacology|December 15, 1992
The influence of pH on the interaction of lipophilic anthracyclines with bovine serum albumin. Quantitative characterization by measurement of fluorescence quenchingL P Rivory, S M Pond, D J Winzor
British Journal of Cancer|August 15, 2002
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase responseL P Rivory, K A Slaviero, S J Clarke
Journal of Pharmaceutical Sciences|January 10, 1998
Photodegradation of irinotecan (CPT-11) in aqueous solutions: identification of fluorescent products and influence of solution compositionH M Dodds, D J Craik, L P Rivory
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Journal of Pharmaceutical and Biomedical Analysis|July 31, 1998
The detection of photodegradation products of irinotecan (CPT-11, Campto, Camptosar), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometryH M Dodds, J Robert, L P Rivory
Clinical Pharmacokinetics|February 24, 2001
Clinical and preclinical pharmacokinetics of raltitrexedS J Clarke, P J Beale, L P Rivory
Cancer Chemotherapy and Pharmacology|January 1, 1996
Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicinL P Rivory, K M Avent, S M Pond
Journal of Chromatography. B, Biomedical Sciences and Applications|October 10, 1998
Trace analysis of SN-38 in human plasma by high-performance liquid chromatographyL P Rivory, M Findlay, S Clarke, et al.
Journal of the National Cancer Institute|January 16, 1999
More about: irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatinH M Dodds, J F Bishop, L P Rivory
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1992
Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugsL P Rivory, M S Roberts, S M Pond
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1993
Physiological pharmacokinetics of solutes in the isolated perfused rat hindlimb: characterization of the physiology with changing perfusate flow, protein content, and temperature using statistical moment analysisZ Y Wu, L P Rivory, M S Roberts
Biochemical Pharmacology|December 15, 1992
The influence of pH on the interaction of lipophilic anthracyclines with bovine serum albumin. Quantitative characterization by measurement of fluorescence quenchingL P Rivory, S M Pond, D J Winzor
British Journal of Cancer|August 15, 2002
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase responseL P Rivory, K A Slaviero, S J Clarke
Journal of Pharmaceutical Sciences|January 10, 1998
Photodegradation of irinotecan (CPT-11) in aqueous solutions: identification of fluorescent products and influence of solution compositionH M Dodds, D J Craik, L P Rivory
Pageof 5